Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 20
2003 16
2004 18
2005 12
2006 16
2007 7
2008 10
2009 5
2010 7
2011 7
2012 4
2013 6
2014 3
2015 3
2016 3
2017 7
2018 6
2019 9
2020 9
2021 14
2022 8
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

172 results

Results by year

Filters applied: . Clear all
Page 1
Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on training, ethical and regulatory issues: Expert Guidelines.
Rossi S, Antal A, Bestmann S, Bikson M, Brewer C, Brockmöller J, Carpenter LL, Cincotta M, Chen R, Daskalakis JD, Di Lazzaro V, Fox MD, George MS, Gilbert D, Kimiskidis VK, Koch G, Ilmoniemi RJ, Lefaucheur JP, Leocani L, Lisanby SH, Miniussi C, Padberg F, Pascual-Leone A, Paulus W, Peterchev AV, Quartarone A, Rotenberg A, Rothwell J, Rossini PM, Santarnecchi E, Shafi MM, Siebner HR, Ugawa Y, Wassermann EM, Zangen A, Ziemann U, Hallett M; basis of this article began with a Consensus Statement from the IFCN Workshop on "Present, Future of TMS: Safety, Ethical Guidelines", Siena, October 17-20, 2018, updating through April 2020. Rossi S, et al. Among authors: brockmoller j. Clin Neurophysiol. 2021 Jan;132(1):269-306. doi: 10.1016/j.clinph.2020.10.003. Epub 2020 Oct 24. Clin Neurophysiol. 2021. PMID: 33243615 Free PMC article. Review.
Pharmacogenetics-based new therapeutic concepts.
Roots I, Gerloff T, Meisel C, Kirchheiner J, Goldammer M, Kaiser R, Laschinski G, Brockmöller J, Cascorbi I, Kleeberg U, Hildebrandt AG. Roots I, et al. Among authors: brockmoller j. Drug Metab Rev. 2004 Oct;36(3-4):617-38. doi: 10.1081/dmr-200033458. Drug Metab Rev. 2004. PMID: 15554239 Review.
Population nutrikinetics of green tea extract.
Scholl C, Lepper A, Lehr T, Hanke N, Schneider KL, Brockmöller J, Seufferlein T, Stingl JC. Scholl C, et al. Among authors: brockmoller j. PLoS One. 2018 Feb 21;13(2):e0193074. doi: 10.1371/journal.pone.0193074. eCollection 2018. PLoS One. 2018. PMID: 29466429 Free PMC article. Clinical Trial.
Atypical Substrates of the Organic Cation Transporter 1.
Redeker KM, Jensen O, Gebauer L, Meyer-Tönnies MJ, Brockmöller J. Redeker KM, et al. Among authors: brockmoller j. Biomolecules. 2022 Nov 9;12(11):1664. doi: 10.3390/biom12111664. Biomolecules. 2022. PMID: 36359014 Free PMC article.
Clinical consequences of cytochrome P450 2C9 polymorphisms.
Kirchheiner J, Brockmöller J. Kirchheiner J, et al. Among authors: brockmoller j. Clin Pharmacol Ther. 2005 Jan;77(1):1-16. doi: 10.1016/j.clpt.2004.08.009. Clin Pharmacol Ther. 2005. PMID: 15637526 Review.
172 results